Chiou-feng T. Lin
1, University Road
Tainan, TNQ 70101, Taiwan
Tainan, TNQ 70101, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 144 publications
Integrative bioinformatics analysis identifies APOE as a candidate link between lipid dysregulation and macrophage activation in inborn errors of metabolism.
Journal: Frontiers in pharmacology
Published: May 14, 2026
Effects of vitamin D3 supplementation on cardiac, muscle, and immune responses after a marathon race: a single-blind, placebo-controlled trial.
Journal: Journal of the International Society of Sports Nutrition
Published: April 12, 2026
Overdose Propofol Emulsion-induced PANoptosis in Human Peripheral Neutrophils: An Ex Vivo Model.
Journal: Anesthesiology
Published: February 12, 2026
Enhancing brain health through resistance exercise: the effect of set number and intensity on brain- derived neurotrophic factor in older adults.
Journal: PeerJ
Published: February 05, 2026
BCL2A1high CD8+ T Cells Are a Survival-Associated Predictor of Immune Checkpoint Blockade Response in Lung Adenocarcinoma.
Journal: Diagnostics (Basel, Switzerland)
Published: January 05, 2026
Lycium barbarum polysaccharides and/or Bifidobacterium longum exert anti-inflammation and modulate gut microbiota in rats with dextran sulfate sodium-induced ulcerative colitis.
Journal: International journal of biological macromolecules
Published: October 02, 2025
Intratumoral SPP1+BCL2A1+ Tumor-Associated Macrophages Predict Poor Response to PD1 Blockade.
Journal: Diagnostics (Basel, Switzerland)
Published: September 29, 2025
Programmable local immunochemotherapy for triple-negative breast cancer via spatiotemporally controlled release of CpG oligodeoxynucleotides, gemcitabine, and paclitaxel.
Journal: NPJ breast cancer
Published: September 14, 2025
An integrated biomarker panel for early computational prediction of dengue severity during the acute phase.
Journal: Clinical immunology (Orlando, Fla.)
Published: August 30, 2025
Genomic analysis unlocks the potential of denosumab as a targeted therapy for Crohn's disease.
Journal: Scientific reports
Published: June 10, 2025
Last Updated: 09/26/2026